高速分拣大细胞的泵
|
By LabMedica International staff writers Posted on 25 Aug 2017 |

图片:微流控芯片能够以16微秒的高速分拣细胞。放大视图展示了片上分拣小眼虫细胞(图片蒙名古屋大学惠赐)。
许多医疗应用场合必须分拣单个细胞,包括从细胞悬液中分离特定的细胞类型。科研人员已经用荧光活化细胞分拣(FACS)做高通量细胞分拣。
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more
Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. These methods can be painful, inconvenient, and... Read moreMolecular Diagnostics
view channel
Urine Test Could Reveal Real Age and Life Span
Chronological age does not always reflect how quickly the body is aging, as biological age is shaped by genetics, stress, sleep, nutrition, and lifestyle factors such as smoking. A higher biological age... Read more
Genomic Test Identifies African Americans at Risk for Early Prostate Cancer Recurrence
Prostate cancer is one of the most commonly diagnosed cancers in men and a leading cause of cancer-related death, particularly in the United States. African American men face a disproportionately higher... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read moreMicrobiology
view channel
New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more
Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read morePathology
view channel
Genetics and AI Improve Diagnosis of Aortic Stenosis
Aortic stenosis is a progressive narrowing of the aortic valve that restricts blood flow from the heart and can be fatal if left untreated. There are currently no medical therapies that can prevent or... Read more
AI Tool Simultaneously Identifies Genetic Mutations and Disease Type
Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read moreTechnology
view channel
Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
Detecting cancer early and tracking how it responds to treatment remains a major challenge, particularly when cancer cells are present in extremely low numbers in the bloodstream. Circulating tumor cells... Read more
AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read moreIndustry
view channel
BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more







